Skip to content
MS
PCCA / PCCB AR unreviewed

Propionic acidaemia

Propionyl-CoA metabolism Propionyl-CoA carboxylase

Enzyme or protein defect

Propionyl-CoA carboxylase

Accumulates or becomes deficient

Propionic acid, 3-hydroxypropionate

Key features

Ketoacidosis, hyperammonaemia, vomiting, hypotonia

Management

Protein restriction, biotin trial, carnitine

Not clinical guidance. Written from standard clinical biochemistry, not from the uploaded documents, and marked unreviewed. Teaching-level reference for study and database seeding only. It must not be used to manage a patient.

Recent literature

Europe PMC · fetched just now · sorted by publication date

  1. 1
    Overcoming hepatic tropism: Precision engineering of lipid nanoparticles for extrahepatic RNA delivery.

    Liu Y, Guo X, Hu Q, Gan C, Nie S, Xiang J, Liu Y, Zou J, Wu X, Li C, Tang Y. · 2026-08-18

    open access unreviewed
  2. 2
    Engineering mRNA-LNP Medicines for the Ageing Brain: Opportunities and Challenges for Neurodegenerative Diseases.

    Belaidi AA, Furtado DL, Alves F, Nisbet RM, Ayton S, Bush AI. · 2026-09-08

    open access unreviewed
  3. 3
    Current status in paediatric liver transplantation for inherited metabolic diseases.

    Hadzic N, Dionisi-Vici C, Vara R. · 2026-06-22

    unreviewed
  4. 4
  5. 5
    Isoleucine and valine promote prostate cancer progression via propionyl-CoA-mediated cholesterol metabolism.

    Li Z, Liu S, Jin W, Xiao L, Kester O, Bullen N, Chen X, Chan UI, Owiredu J, Li Z, Khan R, Endress J, Shafer M… · 2026-08-20

    open access unreviewed
  6. 6
  7. 7
    Energetic stress in combination with impaired fatty acid oxidation induces sequestration of CoA and adaptation of CoA metabolism.

    Kiyuna LA, Odendaal C, Singh M, Gerding A, Langelaar-Makkinje M, van der Zwaag M, Drachman A, Cetkovská V, Ki… · 2026-02-07

    open access unreviewed
  8. 8
    Magnetic resonance imaging features and neurodevelopmental prognosis in infants diagnosed with organic acidaemia.

    Zhang R, Hou X, Liu N, Yang Y, Song J, Zhao Y, Liu L, Zhu Y. · 2025-10-14

    unreviewed
  9. 9
    Simplifying supplementation in MSUD: tolerance and acceptability of liquid valine and isoleucine supplements in maple syrup urine disease.

    Tosi M, Daly A, Evans S, Pinto A, Ashmore C, MacDonald A. · 2026-04-02

    open access unreviewed
  10. 10
    Metabolomic analysis reveals the role of gut microbiota metabolic disorders in heart failure due to congenital heart disease.

    Zhang QL, Ou QX, Wang Y, Liu YN, Zeng YT, Chen Q, Wang ZC. · 2026-04-01

    open access unreviewed

External claims. These come from an index outside this database and are not checked against it. Treat them as leads.